Discovery of 2-thiobenzimidazoles as noncovalent inhibitors of SARS-CoV-2 main protease

The discovery of antiviral agents against SARS-CoV-2 is an important step toward ending the COVID-19 pandemic and to tackle future outbreaks. In this context, the main protease (M(pro)) represents an ideal target for developing coronavirus antivirals, being conserved among different strains and esse...

Descripción completa

Detalles Bibliográficos
Autores principales: Deodato, Davide, Asad, Nadeem, Dore, Timothy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225965/
https://www.ncbi.nlm.nih.gov/pubmed/35760254
http://dx.doi.org/10.1016/j.bmcl.2022.128867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225965/
https://www.ncbi.nlm.nih.gov/pubmed/35760254
http://dx.doi.org/10.1016/j.bmcl.2022.128867

Ejemplares similares